Semmelweis University
semmelweis.huMatched: Semmelweis University Heart and Vascular Center · Semmelweis University
Live pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
158
Active
49
Phase 3
7
Total enrollment
68,432
Pipeline matrix
Showing 16 of 16 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Hydrocortisone | — | — | — | — | 2 | ||
| Extended infusion time of the following beta-lactam: meropenem | — | — | — | — | — | 1 | |
| Short-term infusion time of the following beta-lactam: meropenem | — | — | — | — | — | 1 | |
| Extended infusion time of the following beta-lactam: piperacillin/tazobactam | — | — | — | — | — | 1 | |
| Extended infusion time of the following beta-lactam: cefepime | — | — | — | — | — | 1 | |
| Extended infusion time of the following beta-lactam: ceftriaxone | — | — | — | — | — | 1 | |
| Short-term infusion time of the following beta-lactam: piperacillin/tazobactam | — | — | — | — | — | 1 | |
| Short-term infusion time of the following beta-lactam: cefepime | — | — | — | — | — | 1 | |
| Short-term infusion time of the following beta-lactam: ceftriaxone | — | — | — | — | — | 1 | |
| Caffeine citrate | — | — | — | — | — | 1 | |
| Elixirium thymi compositum | — | — | — | — | — | 1 | |
| Elixirium thymi compositum (FoNo VIII.) placebo | — | — | — | — | — | 1 | |
| Paclitaxel | — | — | — | — | — | 1 | |
| Carboplatin | — | — | — | — | — | 1 | |
| Cyclophosphamide/Doxorubicin | — | — | — | — | — | 1 | |
| Intranasal breast milk | — | — | — | — | — | 2 |
Next readouts
- 2025-09-22
- 2025-10-31
- 2027-06
- 2027-09
- 2027-12
- 2028-01
- 2028-04
Top conditions
- Oral Soft Tissue Conditions4
- Coronary Artery Disease4
- Endometriosis4
- Infertility, Female3
- Alveolar Bone Loss3
- Vitamin D Deficiency3
- Chronic Heart Failure3
- Perinatal Asphyxia3
Frequently asked questions about Semmelweis University
- How many clinical trials does Semmelweis University have on ClinicalTrials.gov?
- Semmelweis University is listed as the lead sponsor on 158 clinical trials in ClinicalTrials.gov, 49 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Semmelweis University's trials are in Phase 3?
- 7 of Semmelweis University's trials are in Phase 3, spread across 16 active drug programs.
- What therapeutic areas does Semmelweis University focus on?
- Semmelweis University's most-studied conditions on ClinicalTrials.gov are Oral Soft Tissue Conditions, Coronary Artery Disease, Endometriosis, Infertility, Female, Alveolar Bone Loss.
- When are Semmelweis University's next clinical trial readouts?
- Semmelweis University has 7 upcoming primary-completion readouts tracked here; the soonest is “Feasibility and Safety of Intranasally Administered Breast Milk in HIE”, expected around 2025-09-22.